The NovaSure procedure is a quick, safe, simple, one-time endometrial ablation treatment. This minimally invasive procedure controls heavy bleeding by using energy to remove the lining of the uterus. The average treatment time is about 90 seconds 1, and only needs to be performed once to lighten or stop your periods. No pretreatment drugs are required and NovaSure can be performed in the hospital or in your doctor's office.
Without the side effects of hormones or the risks of hysterectomy, NovaSure has a quick recovery time so you can get back to your life sooner. Most women experience no pain after the procedure, and can return to work and regular activities the next day.
With more than 500,000 patients treated to date, NovaSure is proven safe and successful. A clinical trial has shown that more than 9 out of 10 women return to normal or lower than normal bleeding levels following treatments with NovaSure. For some women, their periods even stopped completely.
Many women also experienced a reduction in PMS and painful periods, as well as other benefits such as less anxiety, greater self-confidence, and a boost in energy. NovaSure clinical trial post treatment survey results reveal,
Many women find that treatment with NovaSure frees them up to enjoy more of what life has to offer. According to the NovaSure clinical trial post treatment survey, 4 out of 5 women report spending more time at work and daily activities and missing fewer social and athletic events because of heavy bleeding.
A half a million women to date have chosen NovaSure to reduce or eliminate their heavy periods and improve their quality of life. Women are very pleased with the results of the NovaSure procedure; 97% say they would recommend NovaSure to other women.
NovaSure is a procedure for premenopausal women for whom childbearing is complete. If you do not plan to have children in the future, you may want to consider endometrial ablation. In a small percentage of patients, side effects included cramping, nausea/vomiting, discharge, and spotting.